Xeris Biopharma Holdings Inc. buy Oppenheimer Holdings Inc.
Start price
12.11.25
/
50%
€6.66
Target price
12.11.26
€15.55
Performance (%)
-14.12%
Price
19.02.26
€5.72
Summary
This prediction is currently active. The prediction for Xeris Biopharma Holdings Inc. disappoints with a performance of -14.12%. This prediction currently runs until 12.11.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Xeris Biopharma Holdings Inc. | -5.771% | -5.771% |
| iShares Core DAX® | 1,43 % | 2,63 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % |
| iShares S&P 500 | 1,92 % | 1,16 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma (NASDAQ:XERS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc.. They now have a $18.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€8.51
29.10.25
29.10.25
€15.45
29.10.26
29.10.26
-32.80%
19.02.26
19.02.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€4.45
09.05.25
09.05.25
€6.24
09.05.26
09.05.26
28.54%
19.02.26
19.02.26
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.04
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
154.90%
29.03.25
29.03.25